Sirna-027 has hardly anything in common with those early gene-therapy experiments. It is administered locally in the eye and does not use a viral vector
Didn't mean to imply Sirna's drug had Leukemia risks, just new technology wondering how much known about safety profile. I don't claim to understand the science to know the risks (if any).
Dry AMD per se is not such an awful condition that it warrants the kinds of aggressive interventions that are justified for people with the wet form of the disease. It may not lead to blindness like wet, in and of itself but with greatly impacted vision leading to significant loss in quality of life oh and a much greater prevelance I think a drug for Dry AMD (not just stopping progression) would do quite well. Yeah a drug to stop progression would be nice too.
Market Data 
Markets 
AI
